DRUG INEFFECTIVE is the #8 most commonly reported adverse reaction for DULAGLUTIDE, manufactured by Eli Lilly and Company. There are 3,523 FDA adverse event reports linking DULAGLUTIDE to DRUG INEFFECTIVE. This represents approximately 2.3% of all 151,183 adverse event reports for this drug.
Patients taking DULAGLUTIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DRUG INEFFECTIVE3,523 of 151,183 reports
DRUG INEFFECTIVE is a less commonly reported adverse event for DULAGLUTIDE, but still significant enough to appear in the safety profile.
Other Side Effects of DULAGLUTIDE
In addition to drug ineffective, the following adverse reactions have been reported for DULAGLUTIDE:
DRUG INEFFECTIVE has been reported as an adverse event in 3,523 FDA reports for DULAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DRUG INEFFECTIVE with DULAGLUTIDE?
DRUG INEFFECTIVE accounts for approximately 2.3% of all adverse event reports for DULAGLUTIDE, making it a notable side effect.
What should I do if I experience DRUG INEFFECTIVE while taking DULAGLUTIDE?
If you experience drug ineffective while taking DULAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.